US Stock MarketDetailed Quotes
ICCM Icecure Medical
- 1.190
- +0.010+0.85%
Close May 3 16:00 ET
- 1.200
- +0.010+0.84%
Post 16:12 ET
54.42MMarket Cap-3718P/E (TTM)
1.200High1.174Low77.74KVolume1.200Open1.180Pre Close92.67KTurnover0.41%Turnover RatioLossP/E (Static)45.73MShares1.57052wk High4.47P/B22.50MFloat Cap0.52052wk Low--Dividend TTM18.90MShs Float16.000Historical High--Div YieldTTM2.20%Amplitude0.520Historical Low1.191Avg Price1Lot Size
Icecure Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 12.39%-12.52M | 35.95%-2.64M | 0.06%-3.32M | 4.28%-3.62M | 4.02%-2.94M | -13.38%-14.29M | 29.96%-4.13M | -5.37%-3.32M | -120.31%-3.79M | -66.03%-3.06M |
| Net income from continuing operations | 13.70%-14.65M | 24.22%-3M | 1.43%-4M | 13.98%-3.89M | 15.27%-3.77M | -71.58%-16.98M | -25.06%-3.95M | -40.51%-4.06M | -82.59%-4.52M | -224.36%-4.45M |
| Operating gains losses | -106.96%-25K | -93.22%-228K | 223.53%105K | -82.00%90K | -87.10%8K | 7,080.00%359K | -71.01%-118K | -269.57%-85K | 558.72%500K | -69.90%62K |
| Depreciation and amortization | 30.24%323K | 12.16%83K | 17.14%82K | 51.92%79K | 51.92%79K | 95.28%248K | 80.49%74K | 94.44%70K | 92.59%52K | 126.09%52K |
| Change In working capital | 144.39%523K | 129.97%193K | -43.01%163K | 11.95%-221K | -52.86%388K | 106.78%214K | 76.73%-644K | 182.90%286K | -133.33%-251K | 203.13%823K |
| -Change in receivables | -106.61%-25K | -95.76%5K | 183.33%10K | -90.46%25K | -750.00%-65K | 204.42%378K | 131.98%118K | -271.43%-12K | 67.95%262K | 106.41%10K |
| -Change in inventory | 164.52%582K | 333.33%371K | 323.40%105K | 154.13%177K | 80.76%-71K | -1.23%-902K | 12.15%-159K | 84.79%-47K | -23.86%-327K | -169.34%-369K |
| -Change in prepaid assets | -52.76%496K | 125.04%161K | -177.83%-316K | -50.45%277K | -48.63%374K | 151.72%1.05M | 64.20%-643K | 409.92%406K | 9,216.67%559K | 767.89%728K |
| -Change in payables and accrued expense | -26.95%-212K | -659.82%-627K | 242.39%477K | -112.36%-33K | 86.26%-29K | -170.76%-167K | 166.67%112K | -1,057.14%-335K | 92.09%267K | -1,155.00%-211K |
| -Change in other current assets | -25.71%182K | -21.95%64K | -17.65%56K | -78.79%14K | 65.52%48K | 140.36%245K | -29.31%82K | 109.16%68K | 375.00%66K | -32.56%29K |
| -Change in other current liabilities | -28.21%-500K | 242.21%219K | -182.04%-169K | 36.83%-681K | -79.40%131K | -178.63%-390K | 73.45%-154K | -74.09%206K | -245.68%-1.08M | 238.56%636K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 12.39%-12.52M | 35.95%-2.64M | 0.06%-3.32M | 4.28%-3.62M | 4.02%-2.94M | -13.38%-14.29M | 29.96%-4.13M | -5.37%-3.32M | -120.31%-3.79M | -66.03%-3.06M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 19.98%-713K | 440.27%9.06M | 90.74%4.2M | 124.86%1.15M | -10,400.00%-15.12M | -123.50%-891K | 1,036.31%1.68M | 2,139.81%2.2M | -878.01%-4.63M | -103.16%-144K |
| Net PPE purchase and sale | 46.13%-480K | 19.00%-81K | 74.16%-77K | 79.37%-72K | -73.61%-250K | -67.17%-891K | 43.82%-100K | -175.93%-298K | -96.07%-349K | -108.70%-144K |
| Net investment purchase and sale | ---529K | 397.75%8.84M | 71.09%4.28M | 128.57%1.22M | ---14.87M | --0 | 502.03%1.78M | --2.5M | -1,349.83%-4.28M | --0 |
| Net other investing changes | --296K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 19.98%-713K | 440.27%9.06M | 90.74%4.2M | 124.86%1.15M | -10,400.00%-15.12M | -123.50%-891K | 1,036.31%1.68M | 2,139.81%2.2M | -878.01%-4.63M | -103.16%-144K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.39%83K | -99.50%68K | 15K | -56.05%13.58M | -16.40%13.58M | 0 | ||||
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -55.57%13.58M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 4,050.00%83K | 6,700.00%68K | --15K | ---- | ---- | -99.41%2K | -99.70%1K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.39%83K | -99.50%68K | --15K | ---- | ---- | -56.05%13.58M | -16.40%13.58M | --0 | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -7.66%23.66M | -69.24%3.83M | -77.49%3.03M | -74.98%5.59M | -7.66%23.66M | 631.61%25.62M | -19.16%12.44M | -27.64%13.47M | 49.18%22.36M | 631.61%25.62M |
| Current changes in cash | -718.87%-13.15M | -41.76%6.48M | 180.65%900K | 70.59%-2.47M | -463.58%-18.06M | -107.27%-1.61M | 9.41%11.12M | 65.67%-1.12M | -338.99%-8.41M | -127.52%-3.2M |
| Effect of exchange rate changes | 107.02%25K | 132.65%228K | -223.53%-105K | 81.13%-90K | 87.10%-8K | -927.91%-356K | 42.03%98K | 269.57%85K | -537.61%-477K | 60.76%-62K |
| End cash Position | -55.48%10.53M | -55.48%10.53M | -69.24%3.83M | -77.49%3.03M | -74.98%5.59M | -7.66%23.66M | -7.66%23.66M | -19.16%12.44M | -27.64%13.47M | 49.18%22.36M |
| Free cash flow | 14.37%-13M | 35.55%-2.73M | 6.17%-3.39M | 10.62%-3.7M | 0.53%-3.19M | -15.57%-15.18M | 30.37%-4.23M | -11.02%-3.62M | -118.04%-4.13M | -67.57%-3.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg